• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comment on "Durability of response to primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel: OLYMPUS trial final report".

作者信息

Song Yuxuan, Du Yiqing, Qin Caipeng, Xu Tao

机构信息

Department of Urology, Peking University People's Hospital, Beijing, 100044, China.

出版信息

World J Urol. 2022 May;40(5):1251-1252. doi: 10.1007/s00345-022-03968-7. Epub 2022 Feb 22.

DOI:10.1007/s00345-022-03968-7
PMID:35191990
Abstract
摘要

相似文献

1
Comment on "Durability of response to primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel: OLYMPUS trial final report".关于“使用含丝裂霉素的反向热凝胶UGN - 101对低级上尿路尿路上皮癌进行初次化学消融治疗的反应持久性：OLYMPUS试验最终报告”的评论
World J Urol. 2022 May;40(5):1251-1252. doi: 10.1007/s00345-022-03968-7. Epub 2022 Feb 22.
2
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report.使用含丝裂霉素的反向热凝胶 UGN-101 对低级别上尿路尿路上皮癌进行初次化学消融的反应持久性：OLYMPUS 试验最终报告。
J Urol. 2022 Apr;207(4):779-788. doi: 10.1097/JU.0000000000002350. Epub 2021 Dec 17.
3
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.采用含丝裂霉素的反向热凝胶 UGN-101 对低级别上尿路尿路上皮癌进行初级化疗（OLYMPUS）：一项开放标签、单臂、3 期试验。
Lancet Oncol. 2020 Jun;21(6):776-785. doi: 10.1016/S1470-2045(20)30147-9. Epub 2020 Apr 29.
4
Re: Primary Chemoablation of Low-grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-containing Reverse Thermal Gel (OLYMPUS): An Open-label, Single-arm, Phase 3 Trial.
Eur Urol. 2021 Jan;79(1):162. doi: 10.1016/j.eururo.2020.08.020. Epub 2020 Sep 3.
5
An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomas.评估 UGN-101，一种含有丝裂霉素 C 的缓释水凝胶聚合物制剂，用于治疗上尿路上皮癌。
Expert Opin Pharmacother. 2020 Dec;21(18):2199-2204. doi: 10.1080/14656566.2020.1805433. Epub 2020 Sep 1.
6
Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinoma.UGN-101 的药代动力学研究，一种含有丝裂霉素的逆向热凝胶，通过逆行导管给药，用于治疗低级别上尿路尿路上皮癌。
Cancer Chemother Pharmacol. 2021 Jun;87(6):799-805. doi: 10.1007/s00280-021-04246-w. Epub 2021 Mar 7.
7
Primary Chemoablation of Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer Using UGN-102, a Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial.采用含丝裂霉素的反向热凝胶（Optima II）UGN-102 对低级别中危非肌肉浸润性膀胱癌进行初步化学消融：一项 2b 期、开放标签、单臂试验。
J Urol. 2022 Jan;207(1):61-69. doi: 10.1097/JU.0000000000002186. Epub 2021 Aug 26.
8
The ablative effect of mitomycin reverse thermal gel: Expanding the role for nephron preservation therapy in low grade upper tract urothelial carcinoma.丝裂霉素热凝胶的消融作用：拓展了低级别上尿路尿路上皮癌中肾单位保存治疗的作用。
Urol Oncol. 2023 Sep;41(9):387.e1-387.e7. doi: 10.1016/j.urolonc.2023.04.010. Epub 2023 May 26.
9
Early experience with UGN-101 for the treatment of upper tract urothelial cancer - A multicenter evaluation of practice patterns and outcomes.UGN-101治疗上尿路尿路上皮癌的早期经验——实践模式与结果的多中心评估
Urol Oncol. 2023 Mar;41(3):147.e15-147.e21. doi: 10.1016/j.urolonc.2022.10.029. Epub 2022 Nov 22.
10
Route of Administration for UGN-101 and Impact on Oncological and Safety Outcomes.UGN-101 的给药途径及其对肿瘤学和安全性结果的影响。
Eur Urol Focus. 2023 Nov;9(6):1052-1058. doi: 10.1016/j.euf.2023.05.012. Epub 2023 May 30.

本文引用的文献

1
Editorial Comment.
J Urol. 2022 Jun;207(6):1309-1310. doi: 10.1097/JU.0000000000002454.02. Epub 2022 Mar 3.
2
Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration).微创肾输尿管切除术治疗上尿路尿路上皮癌后膀胱内复发的危险因素（ROBUUST 协作组）。
J Urol. 2021 Sep;206(3):568-576. doi: 10.1097/JU.0000000000001786. Epub 2021 Apr 21.
3
Predictors of Intravesical Recurrence After Radical Nephroureterectomy and Prognosis in Patients with Upper Tract Urothelial Carcinoma.根治性肾输尿管切除术后膀胱内复发的预测因素及上尿路尿路上皮癌患者的预后
Cancer Manag Res. 2020 Aug 19;12:7439-7450. doi: 10.2147/CMAR.S261087. eCollection 2020.
4
Retrograde pyelography before radical nephroureterectomy for upper tract urothelial carcinoma is associated with intravesical tumor recurrence.根治性肾输尿管切除术前行逆行肾盂造影与膀胱内肿瘤复发相关。
Int Braz J Urol. 2020 Sep-Oct;46(5):778-785. doi: 10.1590/S1677-5538.IBJU.2019.0503.
5
Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage.在进行肾盂输尿管切除术之前进行诊断性输尿管镜检查，尽管采取了技术预防措施以避免肿瘤溢出，但与膀胱癌复发的高风险相关。
World J Urol. 2020 Jan;38(1):159-165. doi: 10.1007/s00345-019-02768-w. Epub 2019 Apr 16.
6
Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study.根治性肾输尿管切除术治疗上尿路上皮癌的膀胱内复发：来自全国多中心研究的预测因素及其对后续肿瘤学结局的影响。
World J Urol. 2013 Feb;31(1):61-8. doi: 10.1007/s00345-012-0957-3. Epub 2012 Sep 30.